Le Lézard
Classified in: Health, Science and technology, Business, Covid-19 virus
Subject: PDT

Canadian Telemedicine Provider, Wello, Launches COVID-19 Return to Workplace Platform for Employers

Daily risk screening protocol, integrated clinical support and data management capabilities prioritize safety when transitioning employees back into public spaces.

TORONTO, July 13, 2020 /CNW/ - As the Canadian economy continues reopening amidst COVID-19, businesses face many new challenges and considerations in safely welcoming their employees back to their physical workplace. Many employees also have concerns about returning to their workplaces while keeping themselves, their families, and their coworkers safe and healthy.  

In response to client requests for expanded support, Canadian telemedicine provider, Wello, has developed an integrated self-screening & reporting protocol to help manage the risk of bringing COVID-19 into the workplace. Return to Workplace is an online tool that provides companies with accurate, real?time data on the eligibility of their workforce to return to the physical workplace safely. While businesses are not able to fully mitigate the risk of COVID-19 in workplaces, business leaders who require employees to be physically present are given confidence that employees are being supported and directed in taking the necessary steps to provide a protected space.

In alignment with all Canadian provincial and territorial public health guidelines, employees answer a three?part questionnaire in the tool to determine any presence of health risk. If an employee is not eligible to return, they are provided with access to clinical guidance on appropriate next steps and offered the necessary follow-up support to navigate what may feel like a daunting process.

"Businesses can play a role in reducing the spread of COVID-19 by conducting daily fit-for-work screening of employees before entering their physical workplaces. This simple strategy can make a difference and give employees and customers reassurance and confidence that their health and safety is valued and protected," said Dr. Wendy Smeltzer, National Medical Director, Wello.

As we all remain focused on minimizing the spread of the coronavirus, diligent screening, risk management and mental well-being are top priorities. The Return to Workplace platform offers important resources for both employers and employees so that everyone can feel safer and more secure when they must be in a physical work environment. The new platform is now available to all Canadian employers. For more information please visit, https://wello.ca/return-to-the-workplace or contact Randy Wetmore wetmorer@wello.ca.

Wello is a leading Canadian provider of anytime, anywhere virtual healthcare services. Wello healthcare services are available through phone and video visits as well as secure webchat. Backed by a 41?year history of providing high?quality healthcare through its parent company, INLIV, Wello can be offered as part of a company's health benefits for its employees.


These press releases may also interest you

at 16:40
Niclosamide identified as a potent inhibitor of SARS-Cov-2 by Institut Pasteur Korea, with potency >40x higher than remdesivir UNION has advanced niclosamide-based program for COVID-19 (UNI911) to clinical development, currently in Phase 1 study...

at 16:30
Precision Optics Corporation, Inc. , a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced preliminary revenue for the fourth quarter and fiscal year end 2020, ended June 30, 2020....

at 16:30
Grand River Aseptic Manufacturing ("GRAM"), a leading parenteral contract development and manufacturing organization (CDMO), was recognized in Inc. Magazine's Inc. 5000 list for the fourth consecutive year. GRAM's ranking on the Inc. 5000 list, known...

at 16:30
Protagonist Therapeutics, Inc. today announced the appointment of Sarah O'Dowd as an independent director to the Protagonist Board of Directors. Ms. O'Dowd brings broad experience in management and corporate governance to Protagonist, including...

at 16:30
VistaGen Therapeutics, Inc. , a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (CNS) disorders, today reported financial results for its fiscal 2021 first quarter ended June 30,...

at 16:15
INVO Bioscience, Inc. , a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today announced financial results...

News published on 13 july 2020 at 13:56 and distributed by: